Interview: Ming Chua – Partner & Director of Asia, HGP, Singapore

wee-ming-chua-director-hgp-asiaHGP Partner and Director of Asia, Ming Chua on the company’s reasons for using Singapore as the first point of entry into Asia, while highlighting the expansion of the country’s biomedical sciences sector as a major factor in HGP’s consistent year-on-year growth. He also speaks to the company’s qualities in servicing biotech manufacturers in Singapore and details his ambitions of extending HGP’s expertise to local workers beyond the country’s borders. As a European born and bred consultancy, why was Singapore identified as the most ideal destination for HGP’s entry into Asia?
"Starting out in any other place within the region like China, Japan, Korea, or Indonesia, you would have to speak the language and understand the culture, whereas Singapore exhibits a high degree of adaptability when it comes to embracing foreigners."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report